Guggenheim Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Guggenheim Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,632	Closed	-$569K	–	1979
2023 Q1	$569K	Buy	+28,632	New	+$494K	﹤0.01%	1442
2020 Q1	–	Sell	-6,193	Closed	-$301K	–	2048
2019 Q4	$301K	Buy	6,193 +963	+18%	+$43.8K	﹤0.01%	1823
2019 Q3	$249K	Sell	5,230 -1,580	-23%	-$74.2K	﹤0.01%	1928
2019 Q2	$292K	Sell	6,810 -146	-2%	-$5.67K	﹤0.01%	1871
2019 Q1	$269K	Buy	+6,956	New	+$236K	﹤0.01%	1952
2014 Q1	–	Sell	-10,437	Closed	-$358K	–	3379
2013 Q4	$358K	Buy	+10,437	New	+$304K	﹤0.01%	2656
2013 Q3	–	Sell	-9,693	Closed	-$205K	–	3205
2013 Q2	$205K	Buy	+9,693	New	+$188K	﹤0.01%	2740

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Guggenheim Capital's CSII Position: Q2 2023 in Review

Guggenheim Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 28,632 shares — an estimated $569K sold.

Guggenheim Capital first reported a position in CSII in Q2 2013 and held it in 7 quarters. The position peaked at $569K in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Guggenheim Capital reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Guggenheim Capital sold 28,632 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $569K.
Guggenheim Capital first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 7 quarters.
Guggenheim Capital's Cardiovascular Systems, Inc. position peaked at $569K in Q1 2023.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Guggenheim Capital's 13F filing for Q2 2023, filed 11 Aug 2023.